SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 12, 2012
BIOCUREX, INC.
------------------------------
(Name of Small Business Issuer in its charter)
Texas 0-26947 75-2742601
--------------------- ------------------ ------------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
7080 River Road, Suite 215
Richmond, British Columbia , Canada V6X 1X5
-------------------------------------------
(Address of Principal Executive Offices, including Zip Code)
Registrant's telephone number, including area code: (866) 884-8669
N/A
------------------
(Former name or former address if changed since last report)
Item 8.01 Other Events.
A special meeting of Biocurex's shareholders was held on July 31, 2012. At
the meeting the Company's shareholders approved a resolution to reverse split
the Company's common stock by a ratio that would be determined by the Company's
Board of Directors.
The Company's Board of Directors has determined to reverse split the
Company's common stock on a 150-for-1 basis.
The reverse split will become effective on the OTC Bulletin Board when
FINRA has approved the Company's documentation pertaining to the stock split.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: October 12, 2012 BIOCUREX, INC.
By: /s/ Gladys Chan
-------------------------------------
Gladys Chan, Principal Financial Officer
